Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.

[1]  J. Mendell,et al.  AAV-mediated gene therapy to the isolated limb in rhesus macaques. , 2011, Methods in molecular biology.

[2]  H. Stedman,et al.  Gene transfer to muscle from the isolated regional circulation. , 2011, Methods in molecular biology.

[3]  J. Kornegay,et al.  Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  M. Emborg,et al.  Evaluation of hydrodynamic limb vein injections in nonhuman primates. , 2010, Human gene therapy.

[5]  J. Kornegay,et al.  Expression of dog microdystrophin in mouse and dog muscles by gene therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Dexi Liu,et al.  Image-guided, intravascular hydrodynamic gene delivery to skeletal muscle in pigs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Xuan Kong,et al.  Repeatability of nerve conduction measurements derived entirely by computer methods , 2009, Biomedical engineering online.

[8]  B. Byrne,et al.  Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins , 2009, Annals of neurology.

[9]  C. Zhang,et al.  Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. , 2009, Human gene therapy.

[10]  L. Zhou,et al.  A canine minidystrophin is functional and therapeutic in mdx mice , 2008, Gene Therapy.

[11]  T. Grist,et al.  Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. , 2007, Human gene therapy.

[12]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[13]  B. Morrey.  The Diagnostic Value of Intracompartmental Pressure Measurement, Magnetic Resonance Imaging, and Near-Infrared Spectroscopy in Chronic Exertional Compartment Syndrome: A Prospective Study in 50 Patientsvan den Brand JGH, Nelson T, Verleisdonk EJMM, et al (Central Military Hosp, Utrecht, The Netherla , 2006 .

[14]  D. Lewis,et al.  A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  S. Marsch,et al.  0.5% Versus 1.0% 2-Chloroprocaine for Intravenous Regional Anesthesia: A Prospective, Randomized, Double-Blind Trial , 2004, Anesthesia and analgesia.

[16]  L. Pryor,et al.  Definition of venous reflux in lower-extremity veins. , 2003, Journal of vascular surgery.

[17]  M. Comunale.  A Laboratory Evaluation of the Level 1 Rapid Infuser (H1025) and the Belmont Instrument Fluid Management System (FMS 2000) for Rapid Transfusion , 2003, Anesthesia and analgesia.

[18]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[19]  J. Mendell,et al.  Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors. , 2000, Human gene therapy.

[20]  Alan McClelland,et al.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.

[21]  M B Bromberg,et al.  The influence of active electrode placement on CMAP amplitude. , 1997, Electroencephalography and clinical neurophysiology.

[22]  B. Byrne,et al.  Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Plante,et al.  Consequences of alteration in capillary permeability. , 1996, Canadian journal of physiology and pharmacology.

[24]  B. Demeneix,et al.  Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. , 1993, Human gene therapy.

[25]  P. Briand,et al.  Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice , 1993, Nature.

[26]  J. Miller,et al.  Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.

[27]  D. Newham,et al.  An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy , 1987, Muscle & nerve.

[28]  M. Brooke,et al.  Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy , 1985, Neurology.

[29]  J. R. Roberts.  Intravenous regional anesthesia--'Bier block'. , 1978, American family physician.